Results
|
2061.
|
|
|
2062.
|
|
|
2063.
|
|
|
2064.
|
|
|
2065.
|
|
|
2066.
|
|
|
2067.
|
|
|
2068.
|
|
|
2069.
|
|
|
2070.
|
|
|
2071.
|
Phase I study of GTI-2040, an antisense to ribonucleotide reductase, in combination with high-dose cytarabine in patients with acute myeloid leukemia. [electronic resource] by
- Klisovic, Rebecca B
- Blum, William
- Wei, Xiaohui
- Liu, Shujun
- Liu, Zhongfa
- Xie, Zhiliang
- Vukosavljevic, Tamara
- Kefauver, Cheryl
- Huynh, Lenguyen
- Pang, Jiuxia
- Zwiebel, James A
- Devine, Steven
- Byrd, John C
- Grever, Michael R
- Chan, Kenneth
- Marcucci, Guido
Producer: 20080925
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 14
Availability: No items available.
|
|
2072.
|
|
|
2073.
|
|
|
2074.
|
|
|
2075.
|
|
|
2076.
|
|
|
2077.
|
|
|
2078.
|
|
|
2079.
|
|
|
2080.
|
|